Ryan Fuhrmann

About the Author Ryan Fuhrmann

Ryan C. Fuhrmann, CFA, founded Fuhrmann Capital after coming to the realization that aspects of the investment profession serve Wall Street well, but not necessarily the needs of individual and related investors on Main Street. Ryan has nearly 25 years of experience in the investment field and focuses on developing close working relationships with his clients to help them attain their financial goals. He seeks a comprehensive understanding of client return objectives, risk tolerances, liquidity needs, investment time horizons, tax profiles, retirement goals and estate planning needs. Ryan stands apart from the industry in that he emphasizes performance and fees as important topics for his clients consider.

RBC: 3 Beaten-Down Media Stocks to Buy for a Rebound

Nielsen, a preeminent firm that tracks media trends such as how much television programming consumers watch, recently suggested that stay-at-home orders and social …

JPMorgan: 2 High-Yield Dividend Stocks to Snap Up (And 1 to Avoid)

The investment adage that the market hates uncertainty is oft cited and arguably playing out since the coronavirus and a coordinated national effort …

Needham: 3 Top-Notch Stocks to Buy for a Volatile 2020

The stock market is currently caught in a somewhat volatile trading range. The news headlines are far from pretty – the ranks of …

3 Spinoff Stocks Ready to Soar on Their Own

Wall Street loves mergers and acquisitions. They feed the egos of CEOs by increasing their empires and garner big fees for the bankers …

3 High-Powered Dividends Stocks With Over 7% Dividend Yield

After weeks of historic uncertainty, global stock markets are quickly settling down from now what is now nearly a month of record share …

3 Under-The-Radar Dividend Stocks With Over 8% Dividend Yield

What’s the most important investment metric an investor can focus on in the midst of a downturn? My vote is cash flow.

3 Biotech Stocks Fighting the Coronavirus; Here’s What to Expect

A saying on Wall Street is that the market hates uncertainty, and unfortunately that looks to be playing out in global stock markets …

Needham: Our Best 3 Top Ideas for COVID-19 Stabilization

After nearly a decade of steady stock returns, U.S.

3 Blue-Chip Stocks to Buy for an Earnings Bump

Mr. Market is in the midst of third-quarter earnings season.

3 Top Biotech Stocks With Major Catalysts in October

Along with healthcare stocks in general, biotechnology stocks are not hitting any near-term highs in terms of share price performance. Chalk it up …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts